Lv1
40 积分 2024-08-21 加入
THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
1个月前
已完结
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
3个月前
已完结
Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ‐II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL)
4个月前
已完结
[Conservative therapy in the treatment of cervical chylous leakage]
4个月前
已完结
Measurement of patient outcome in arthritis
4个月前
已完结
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
6个月前
已完结
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
6个月前
已完结
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
6个月前
已完结
[The standardized diagnosis and treatment of rheumatoid arthritis]
7个月前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
7个月前
已完结
皖公网安备34019202002308
